UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Cupid 2b: Enzyme Replacement Therapy for Advanced Heart Failure
    Frances Johnson
  2. Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
    Mohammed Milhem
  3. Targeting Inflammation to Treat Cardiovascular Aging in Humans
    Gary L. Pierce
  4. Adolescent Brain Development - No History
    Daniel O'Leary
  5. A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study of the Safety, Tolerability, and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in…
    Jeffery Meier
  6. Expanded Access of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
    Margarida Magalhaes-Silverman
  7. Neuropsychological, Social Emotional, and Behavioral Outcomes in Children with Cancer
    Ayman El-Sheikh
  8. Interagency Registry of Mechanically Assisted Circulatory Support (INTERMACS)
    Jennifer Goerbig-Campbell
  9. A Trial of Intensive Multi-Modality Therapy for Extra-Ocular Retinoblastoma
    Ayman El-Sheikh
  10. Investigational Drug Trial for Patients with Multiple Myeloma
    Mohammed Milhem
  11. [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
    Sarah McGuire
  12. A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (LEPHT)
    KellyAnn Light-McGroary
  13. A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab (IND #113911, NSC #704865) to gemcitabine, cisplatin, and placebo in patients with advanced transitional c…
    Daniel Vaena
  14. High-Frequency OAEs and Ototoxicity
    Shawn Goodman
  15. SynCardia CardioWest TAH-t Postmarket Surveillance Study
    Jennifer Goerbig-Campbell
  16. RTOG 1010: A phase III trial evaluating the addition of trastuzumab to trimodality treatment of HER2-overexpressing esophageal adenocarinoma
    Mark C. Smith
  17. A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab (IND #7921, NSC #704865) to gemcitabine, cisplatin, and placebo in patients with advanced transitional cel…
    Daniel Vaena
  18. A randomized double-blind, placebo-controlled study of LEE011 in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive, HER2-negative, advanced breast can…
    Alexandra Thomas
  19. Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program (PAH QuERI Ext)
    Linda Cadaret
  20. Safety Study of Ambrisentan in Subjects With Pulmonary Hypertension
    Alicia Gerke

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.